Sherly mosessian, phd, sofie’s chief scientific officer, has been recognized by the organization women we admire, as one of the top 25 women chief scientific [.] Our team works alongside our pharma and academic partners to revolutionize clinical diagnostics and therapeutics to better understand and treat the biology of disease. In 2006, the creation of sofie launched the aspiration of having a multifaceted approach to expand the reach of pet products for patients with advanced imaging needs
This was further realized in 2017 with the addition of a radiopharmacy network with global distribution capabilities. Our product lines include fdg, pylarify, neuraceq, and other clinical trial products. Transparency in coverage (tic) regulations requires health insurers and group health plans to post their provider link on company websites
